Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Alpha-9 Oncology USA Inc.
Centre Oscar Lambret
Emory University
MonTa Biosciences ApS
Replimune Inc.
Mayo Clinic
M.D. Anderson Cancer Center
Fusion Pharmaceuticals Inc.
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
OncoNano Medicine, Inc.
Modulation Therapeutics, Inc.
TriSalus Life Sciences, Inc.
Novelty Nobility, Inc.
Vastra Gotaland Region
Vastra Gotaland Region
Emory University
Memorial Sloan Kettering Cancer Center
Vastra Gotaland Region
Turnstone Biologics, Corp.
University of Michigan Rogel Cancer Center
Foghorn Therapeutics Inc.
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Perspective Therapeutics
Columbia University
Vastra Gotaland Region
Viralytics
Provectus Pharmaceuticals
Hoffmann-La Roche
Novartis
Opna Bio LLC
Pfizer
Incyte Corporation
Novartis
Iconic Therapeutics, Inc.
Polaris Group
Jonsson Comprehensive Cancer Center
Centre Hospitalier Universitaire Vaudois
University of Pittsburgh
Memorial Sloan Kettering Cancer Center
University of Virginia
Massachusetts Eye and Ear Infirmary
Polaris Group
Children's Oncology Group
University of Southern California
University of Southern California
Memorial Sloan Kettering Cancer Center
The New York Eye Cancer Center